The Impact of B-type Natriuretic Peptide, New York Heart Association Classification and Depression on Quality of Life in Nonhospitalized Heart Failure Patients

Healthcare providers should be concerned with improving the quality of life (QOL) of patients with heart failure (HF) because disease‐specific QOL is linked to disease progression. The present study investigated the significance of elevated b‐type natriuretic peptide (BNP), NYHA classification and depression to HF‐related QOL to develop better management strategies. Outpatient subjects with left ventricular systolic dysfunction ( n =108; mean...